BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 14747617)

  • 1. Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes.
    Forrest M; Sun SY; Hajdu R; Bergstrom J; Card D; Doherty G; Hale J; Keohane C; Meyers C; Milligan J; Mills S; Nomura N; Rosen H; Rosenbach M; Shei GJ; Singer II; Tian M; West S; White V; Xie J; Proia RL; Mandala S
    J Pharmacol Exp Ther; 2004 May; 309(2):758-68. PubMed ID: 14747617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.
    Mandala S; Hajdu R; Bergstrom J; Quackenbush E; Xie J; Milligan J; Thornton R; Shei GJ; Card D; Keohane C; Rosenbach M; Hale J; Lynch CL; Rupprecht K; Parsons W; Rosen H
    Science; 2002 Apr; 296(5566):346-9. PubMed ID: 11923495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 4(5)-phenylimidazole-based analogues of sphingosine-1-phosphate and FTY720: discovery of potent S1P1 receptor agonists.
    Clemens JJ; Davis MD; Lynch KR; Macdonald TL
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3568-72. PubMed ID: 15982878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P3 receptor: investigation based on a new S1P3 receptor antagonist.
    Murakami A; Takasugi H; Ohnuma S; Koide Y; Sakurai A; Takeda S; Hasegawa T; Sasamori J; Konno T; Hayashi K; Watanabe Y; Mori K; Sato Y; Takahashi A; Mochizuki N; Takakura N
    Mol Pharmacol; 2010 Apr; 77(4):704-13. PubMed ID: 20097776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1.
    Matloubian M; Lo CG; Cinamon G; Lesneski MJ; Xu Y; Brinkmann V; Allende ML; Proia RL; Cyster JG
    Nature; 2004 Jan; 427(6972):355-60. PubMed ID: 14737169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular mechanism through the Edg family of receptors might be responsible for sphingosine-1-phosphate-induced regulation of DNA synthesis and migration of rat aortic smooth-muscle cells.
    Tamama K; Kon J; Sato K; Tomura H; Kuwabara A; Kimura T; Kanda T; Ohta H; Ui M; Kobayashi I; Okajima F
    Biochem J; 2001 Jan; 353(Pt 1):139-146. PubMed ID: 11115407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selecting against S1P3 enhances the acute cardiovascular tolerability of 3-(N-benzyl)aminopropylphosphonic acid S1P receptor agonists.
    Hale JJ; Doherty G; Toth L; Mills SG; Hajdu R; Keohane CA; Rosenbach M; Milligan J; Shei GJ; Chrebet G; Bergstrom J; Card D; Forrest M; Sun SY; West S; Xie H; Nomura N; Rosen H; Mandala S
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3501-5. PubMed ID: 15177461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.
    Walter DH; Rochwalsky U; Reinhold J; Seeger F; Aicher A; Urbich C; Spyridopoulos I; Chun J; Brinkmann V; Keul P; Levkau B; Zeiher AM; Dimmeler S; Haendeler J
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):275-82. PubMed ID: 17158356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors.
    Gräler MH; Goetzl EJ
    FASEB J; 2004 Mar; 18(3):551-3. PubMed ID: 14715694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells.
    Yamaguchi H; Kitayama J; Takuwa N; Arikawa K; Inoki I; Takehara K; Nagawa H; Takuwa Y
    Biochem J; 2003 Sep; 374(Pt 3):715-22. PubMed ID: 12803545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes.
    Robert P; Tsui P; Laville MP; Livi GP; Sarau HM; Bril A; Berrebi-Bertrand I
    J Mol Cell Cardiol; 2001 Sep; 33(9):1589-606. PubMed ID: 11549339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of cell motility observed with high doses of sphingosine 1-phosphate or phosphorylated FTY720 involves RGS2 through its interactions with the receptor S1P.
    Kohno T; Igarashi Y
    Genes Cells; 2008 Jul; 13(7):747-57. PubMed ID: 18513330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice.
    Keul P; Tölle M; Lucke S; von Wnuck Lipinski K; Heusch G; Schuchardt M; van der Giet M; Levkau B
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):607-13. PubMed ID: 17158351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine-1-phosphate-induced airway hyper-reactivity in rodents is mediated by the sphingosine-1-phosphate type 3 receptor.
    Trifilieff A; Fozard JR
    J Pharmacol Exp Ther; 2012 Aug; 342(2):399-406. PubMed ID: 22570366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative property of sphingosine 1-phosphate in rat hepatocytes involves activation of Rho via Edg-5.
    Ikeda H; Satoh H; Yanase M; Inoue Y; Tomiya T; Arai M; Tejima K; Nagashima K; Maekawa H; Yahagi N; Yatomi Y; Sakurada S; Takuwa Y; Ogata I; Kimura S; Fujiwara K
    Gastroenterology; 2003 Feb; 124(2):459-69. PubMed ID: 12557151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cis-4-methylsphingosine is a sphingosine-1-phosphate receptor modulator.
    Ter Braak M; Claas RF; Hegen B; Labocha S; Ferreirós N; Pfeilschifter J; Huwiler A; van Echten-Deckert G; Meyer Zu Heringdorf D
    Biochem Pharmacol; 2011 Mar; 81(5):617-25. PubMed ID: 21163254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tipping the gatekeeper: S1P regulation of endothelial barrier function.
    Rosen H; Sanna MG; Cahalan SM; Gonzalez-Cabrera PJ
    Trends Immunol; 2007 Mar; 28(3):102-7. PubMed ID: 17276731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the lysophospholipid sphingosine 1-phosphate in immune cell biology.
    von Wenckstern H; Zimmermann K; Kleuser B
    Arch Immunol Ther Exp (Warsz); 2006; 54(4):239-51. PubMed ID: 16830220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720.
    Hale JJ; Neway W; Mills SG; Hajdu R; Ann Keohane C; Rosenbach M; Milligan J; Shei GJ; Chrebet G; Bergstrom J; Card D; Koo GC; Koprak SL; Jackson JJ; Rosen H; Mandala S
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3351-5. PubMed ID: 15149705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology.
    Brinkmann V
    Pharmacol Ther; 2007 Jul; 115(1):84-105. PubMed ID: 17561264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.